Cited by 67Histone Deacetylase Inhibitors ResearchGut microbiota and healthCancer, Lipids, and Metabolism

Uptake and Metabolism of the Short-Chain Fatty Acid Butyrate, a Critical Review of the Literature

M. Astbury, Stuart, M. Corfe, Bernard·2012·Current Drug Metabolism

Abstract

Butyrate is a short-chain fatty acid (SCFA) formed by bacterial fermentation of fibre in the colon, and serves as an energy source for colonocytes. The action of butyrate as a histone deacetylase inhibitor (HDACi) has led to a number of clinical trials testing its effectiveness as a potential treatment for cancer. The biology of butyrate transport is therefore relevant to both its physiological and pharmacological benefits. This review of the literature was carried out to assess the evidence for both the uptake and metabolism of butyrate, in an attempt to determine possible mechanism (s) by which butyrate can act as an HDACi. It is noted that although uptake and metabolism are well characterised, there are still significant gaps in the knowledgebase around the intracellular handing of butyrate, where assumptions or dated evidence are relied upon.

Integrity signals

Registry

Crossref · 10.2174/138920012800840428

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SCFAs are energy substrates for numerous tissue types, including the colon, adipose, and muscle tissues.

    “SCFAs are also energy substrates for numerous tissue types, including the colon [227], adipose [228] and muscle tissues [224]”

    From The athletic gut microbiota (2020) · cites this paper as [227]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
M. Astbury, S., & M. Corfe, B.
Venue
Current Drug Metabolism
Published
2012-06-01
Volume
13
Issue
6
Pages
815-821
ISSN
1389-2002 (ISSN-L)
OpenAlex
W2094732391
Cited by
67
References
64
Citations by year
2026: 3 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 5 · 2014: 7 · 2013: 2 · 2012: 2
FWCI
2.06
Type
journal article
Language
en
Open access
closed
Locations
  • Current Drug Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
butyrate, short-chain fatty acids, butyrate metabolism, histone deacetylase inhibitors, colonic fermentation, dietary fiber, cancer therapy
MeSH terms
Animals, Biological Transport, Butyrates, Humans, Oxidation-Reduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review